Theme: Pathogenesis and New Methods in Bacteriology and Infectious
It is great honour and privilege to have the opportunity to invite all the Speakers, Delegates, Researchers, students and Industrialists to address our 11th international conference on Bacteriology and infectious diseases on December 17-18,2021,virtually .Our allegiance to discuss the new technology, new products, service your industry may bid to a broad international audience and scientific innovations with one another will openly embody this year’s theme, “Bacteriology and infectious diseases. We whole heartedly welcome you to share your innovative ideas, experience and knowledge in this conference by interacting with worldwide experts from the recent researches on bacteriology and infections. The conference includes Keynote lectures, Oral and Poster presentations. On behalf of the Organizing Committee 2021 of we would love to express our warm welcome to all of you who are participating in Bacteriology 2021, and wish you will appreciate and make aware of each other.
Why to attend?
Bacteriology 2021 is a great and enthusiastic opportunity have been designed in an interdisciplinary manner with a multitude of tracks to showcase the new technology, the new products, and the service your industry may bid to a broad international audience. It covers a huge of topics and it will be a nice platform to show their recent researches on Bacteriology and infectious diseases 2021. Bacteriology 2021 host presentations from specialists and experts across the world in the field of bacteriology and anticipates more than 200 participants around the world with thought provoking Keynote lectures, Oral and Poster presentations. The attending delegates comprise Editorial Board Members of associated international journals.
Young Scientist Benefits
- Our conference provides best aim for your research through oral presentations.
- Share the thoughts with both eminent researchers and mentors. We will provide Young Scientist Award reorganization certificate and memento to the winners.
- Young scientists will get significant and timely information by this Forum.
- Podium for collaboration among young researchers for better development Award should motivate participants to strive to realize their full potential which could in turn be beneficial to the field as whole.
- We look forward to see you in webinar.
Track -1: Microbes
Antibiotic resistance is a serious public health problem. Some bacteria that are able of causing serious disease are becoming resistant to most commonly available antibiotics. Antibiotic resistant bacteria can develop from person to person in the community or from patient to patient in hospital. All thermophiles require a hot water environment, but some thrive in more than one extreme, such as those with high levels of sulphur or calcium carbonate, acidic water, or alkaline springs. Most of them are resistant at 140 C. In many organisms, the genes controlling metal resistance are transferred on plasmids, which provide the bacteria with a competitive advantage over other organisms when metals are present. Not all metal-resistant bacteria consists plasmids. Acid resistance is an important capability that E.coli possesses to survive low pH and flourish. Indeed, E. coli organisms can be so resistant to low pH that they survive gastric acid, colonize the gut, and cause diseases .
- Antibiotic Resistant Microbes
- Thermal Resistant Microbes
- Metal resistant microbes
- Acid resistant microbes
Track -2: Plant Microbiology
Microorganisms interrelate with plants because plants offer a wide diversity of habitats including the phyllosphere (aerial plant part), the rhizosphere (zone of impact of the root system), and the endosphere (internal transport system). Interactions of epiphytes, rhizophytes or endophytes may be detrimental or beneficial for either the microorganism or the plant and may be divided as Neutralism, Commensalism, Synergism, Mutualism, Amensalism, Competition or Parasitism.
Associations: Royal Health Awareness Society |International Society for Infectious Diseases |Infectious Diseases and Clinical Microbiology Specialty Society of Turkey |Bulgarian Association for Prevention and Infection Control
Track -3: Food microbiology
Many pathogenic micro-organisms can contaminate foods during various stages of their handling , between production and consumption. Consumption of these foods can cause food borne diseases. Food borne diseases can be fatal and may also seeds large economic losses. Foods of animal origin are associated, huge with food borne diseases than foods of plant origin. Various groups of micro-organisms and their relation with food such as Food-borne disease, Food spoilage, Food fermentations, Production of food additives and enzymes.
- Food Borne Diseases
- Food Spoilage
- Food Fermentation
Associations: Nordic Society of Clinical Microbiology and Infectious Diseases |European Society for Clinical Virology (ESCV)|Turkish Society of Clinical Microbiology Infectious Diseases (KLIMIK)|French Society of Microbiology (SFM)
Track -4: Industrial and Applied Bacteriology
Fermentation processes used in the ancient world to make wine and bread demonstrate how applied microbiology is twirl with human history. In the modern era, the developing applications for microorganisms and their products are vast and incorporate the generation of high-value products such as drugs, chemicals, fuels and even electricity. Furthermore, recent advances in systems biology and synthetic biology now make it possible to engineer desirable features in a microorganism, allowing them to be tailored to a specific task. Bacteria are capable of producing a vast diversity of polymers dealing a level of biological functions, such as reserve material, protective capsules and slimes, and biofilm matrix components.
- Bio Polymers
- Food Fermentations
Track -5: Veterinary Bacteriology
The field of Veterinary Bacteriology plays a major role in veterinary medicine, human health, and economics. This outline describes representative bacteria that are pathogenic and can cause infectious diseases to animals. Others are potential infectious agents to humans, and they can threaten public health. In addition, the result of a disease may lead to an economic loss, especially for farm animals, wildlife, and companion animals.
Track -6: Mechanism of Resistant Bacteria
Bacterial pathogens express a wide range of molecules that bind host cell targets to facilitate a variety of different host responses. The molecular strategies used by bacteria to interchange with the host can be unique to specific pathogens across several different species. Antibiotic resistance can be either plasmid mediated on the bacterial chromosome.
- Enzymatic Degradation of Antibacterial Drugs
- Alteration of Bacterial Proteins that are Antimicrobial Targets
- Modifications in Membrane Permeability to Antibiotics.
Track -7: Emerging Infectious Diseases
Emerging infectious diseases are a significant burden on global economies and public health. Their emergence is thought to be operated largely by socio-economic, environmental and ecological factors, but no comparative study has explicitly investigated these linkages to understand global temporal and spatial patterns of emerging infectious diseases. EID events are dominated by zoonosis (61.3% of emerging infectious diseases) the majority of these (72.8%) originate in wildlife.
Track -8: Hospital Infections
Hospital-acquired infections are one of the main causes of morbidity and mortality in hospitalized patients at the present time, leading directly or indirectly to an vast increase in the cost of hospital care and to the emergence of new health hazards for the community. Although some success has been achieved in controlling infections spreading in hospitals, current advances in biomedical technology and therapeutics are producing greater numbers of highly susceptible patients, and this is antagonize by the occurrence of transferrable resistance to antibiotics in pathogenic organism.
Track -9: Paediatrics Infections
Neonatal infections may be contracted by mother to child transmission, in the birth canal during childbirth, or contracted after birth. Some neonatal infections are apparent soon after delivery, while others may develop in the postnatal period. Few neonatal infections such as HIV, hepatitis B, and malaria do not become apparent until much later. There is a higher risk of infection for preterm or low birth weight neonates. Infant respiratory distress syndrome is often a condition of preterm neonates that can have long-term negative consequences; it can also arise following an infection. In some instances, neonatal respiratory tract diseases may increase the susceptibility to upcoming respiratory infections and inflammatory reactions related to lung disease. Antibiotics can be effective for neonatal infections, especially when the pathogen is rapidly identified. Instead of relying solely on culturing techniques, pathogen identification has improved essentially with advancing technology.
- Neo Natal Infectious
- Child Infections
Track -10: Bacterial Oncogenesis
Understanding bacterial carcinogenesis has become rising important as a possible means of cancer prevention. These bacteria might affect disease occurrence in the human host is rightly a vigorous place of research. As cancer continues its mount as the leading cause of death in developed nations, understanding the long-term effects of bacteria has grace increasingly important as a practicable means of cancer prevention.
Track -11: Eradication of Infectious Diseases
Eradication is the reduction of an infectious disease's prevalence in the global host population to zero. Two infectious diseases have successfully been eradicated: smallpox in humans and rinderpest in ruminants. There are four on-going programs, targeting the human diseases poliomyelitis (polio), yaws, dracunculiasis (Guinea worm) and malaria. Some of viral and bacterial have been eradicated by new technology.
The concept of disease eradication is sometimes confused with disease elimination, which is the depletion of an infectious disease's prevalence in a regional population to nil, or the reduction of the global prevalence to a negligible amount.
Track -12:GMO and Drug Synthesis
The interaction between chemical and biological approaches to drug discovery and development is increasing with the advent of combinatorial methods that accelerate the output of screening programs and the development of genetically modified microorganisms able to make new metabolites and larger amounts of known ones. Actinomycetes, the most prolific microbial source of known drugs, can produce new aromatic compounds by manipulation of the Type II polypeptide synthase genes as well as analogues of existing macrolide antibiotics, unavailable by chemical synthesis, through targeted mutation of specific biosynthetic genes. Genetic remodelling of pathways to aminoglycoside and oligopeptide antibiotics should offer equivalently promising approaches to manufacturing novel metabolites. When coupled with DNA-based prescreening of microbial isolates for genes associated with known pharmacologically active agents, these new genetic-based proposals are constructing an expanded role for microorganisms in drug research.
Track -13: Advanced In Antimicrobial Vaccines
Vaccines are used prophylactically, decreasing the number of infectious disease cases, and thus antibiotic use and the emergence and spread of AMR. Expressing the current state of development of vaccines against resistant bacterial pathogens that cause a substantial disease burden both in high-income countries and in low- and medium-income countries, discuss workable obstacles that hinder progress in vaccine development and wonder on the impact of next-generation vaccines against bacterial infectious diseases on Anti-Microbial Resistance.
Track -14: Diagnosis and Revitalized Therapies
Emerging microbiological techniques that help the rapid diagnosis of bacterial infections in critically ill patients, including their performance, strengths and pitfalls, as well as available data evaluating their clinical impact. New diagnostic methods able to overcome the limits of traditional microbiology in terms of turn-around time and validity are highly warranted.
- Culture-Based Methodologies
- PCR Assays and Microarrays
- Sepsis Biomarke
Molecular techniques and Microbiology brought out new technology for treating infections. Now day’s experts are producing therapies with various agents such as: gene therapy, bacteriophage therapy, etc. Bacteriophage (phage) therapy necessitates using phages or their products as bio agents for the treatment or prophylaxis of bacterial infectious diseases. Much evidence in support of the effectiveness of phage therapy against bacterial infectious diseases has cumulated since 1980 from animal model studies conducted in Western countries. Reports indicate that appropriate administration of living phages can be used to treat lethal infectious diseases caused by gram-negative bacteria and gram-positive bacteria so.
Track -15: Immunization
Immunization is a key component of primary health care and an indisputable human right. It’s also one of the best health investments money can buy. Vaccines are also critical to the prevention and control of infectious-disease outbreaks. They underpin global health security and will be a essential tool in the battle against antimicrobial resistance.
Track -16) Disinfection and Sterilisation
Disinfection and sterilization are essential for ensuring that medical and surgical instruments don’t transmit infectious pathogens to patients. Because sterilization of all patient-care items is not necessary, health-care policies must identify, primarily on the basis of the items intended use, whether cleaning, disinfection, or sterilization is indicated.
- Physical Methods
- Chemical Methods
- Mechanical Methods
Track -17: Personal Hygiene Practices
One of the most effective ways we have to protect ourselves and others from illness is good personal hygiene. Washing your hands, especially, but also your body. It means being careful not to cough or sneeze on others, cleaning things that you touch if you are unwell, putting items such as tissues (that may have germs) into a bin, and using protection (like gloves or condoms) when you might be at risk of catching an infection.Personal hygiene, such as bathing, is very indeed dependent on the culture in which you live. In some cultures, it is expected that you will wash your body at least every day and use deodorants to stop body smells. Other cultures have different expectations.
Track -18: Control Strategies of Infections
Healthcare-associated infections such as central line-associated bloodstream infections, catheter-associated urinary tract infections, ventilator-associated Pneumonias, and surgical site infections represent a major challenge for healthcare today. These infections are often caused by Multidrug-Resistant Organisms such as methicillin-resistant Staphylococcus aureus, Vancomycin resistant Enterococci, and Carbapenem-resistant Enterobacteriaceae. Infection control strategies create to prevent the spread of these infections can be grouped into two categories: vertical and horizontal. Vertical strategies focus on a single organism while horizontal strategies aim to control the spread of multiple organisms simultaneously.
- Vertical Strategies
- Horizontal Strategies
Track -19: Neuro-Diseases
This field presents the interactions between the microbiome and the central nervous system. The microbiome has a tremendous impact on human health. The gut microbiota may play a key role in many essential processes in health and disease via the activity of the gut-brain axis, possibly creating to autism spectrum disorders, Alzheimer’s disease, Parkinson’s disease, depression, and anxiety disorder. Gut microbes may also be involved in nociception, complex host behaviors, and brain development. Future efforts will be essential to determine whether the observed associations correspond to causative mechanisms, as well as to engineer effective interventions to modulate the effects of the microbiome on the central nervous system.
The global infectious disease therapeutics market size was valued at USD 46.88 billion in 2016. It is expected to grow at a CAGR of 6.8% during the forecast period. The growing frequency of infectious ailments, increasing expenditure to boost the penetration rate of treatments of these diseases, diagnosis, rising initiatives for creating awareness about treatments and increasing clinical trials are the feature responsible for growth of this market. India and China are both considered to be the fastest growing infectious diseases therapeutics markets. The key companies which play a lively role in the global infectious diseases therapeutics market are, Pfizer, Johnson & Johnson, Merck & Co., GlaxoSmithKline Pharmaceuticals, F. Hoffmann-La Roche, Inc., Novartis, Achillion Pharmaceuticals, Eli Lilly and Company, Isis Pharmaceuticals , Gilead Sciences and Sanofi.
Diagnostic Market Research on Infectious Diseases
Infectious Diseases diagnostic market is studied with reference to four regions like North America, Europe, and Asia Pacific. Among all of those North America is dominating the entire region followed by Europe. communicable disease diagnostic market is anticipated to grow during the forecast period due to the expanding prevalence of varied infectious diseases like , malaria, Lyme disease , fifth disease, TB, HIV/AIDS, hepatitis , HAIs, MRSA, STDs and diarrheal diseases. The opposite vital areas of this market are growing order of rapid diagnostic procedure over existing technique thanks to long turnaround and government aided funding. The several methods used for diagnosis are microbiological techniques, clinical laboratory techniques and medical care medicine.
In the new bio-economy, Infectious diseases play a very important role in constituting major global challenges, upgrading waste streams to valuable food ingredients, counteracting life-style diseases and antibiotic resistance through the gut biota, making crop plants more resistance to utmost climatic substitute conditions, and functioning as host for the production of new biological drugs for treatments of diseases.
Infectious Diseases Associations & Societies around the Globe:
- International Society of Antimicrobial Chemotherapy (ISAC)
- Emirates Medical Association (EMA)
- UAE Rare Disease Society
- Emirates Neurology Society
- Royal Health Awareness Society
- International Society for Infectious Diseases
- Infectious Diseases and Clinical Microbiology Specialty Society of Turkey
- Bulgarian Association for Prevention and Infection Control
- Nordic Society of Clinical Microbiology and Infectious Diseases (NSCMID)
- European Society for Clinical Virology (ESCV)
- Turkish Society of Clinical Microbiology Infectious Diseases (KLIMIK)
- French Society of Microbiology (SFM)
- Albanian Society of Infectious Disease (SHSHI)
- Danish Infectious Disease Society
- Swedish Society of Clinical Microbiology (FKM)
- French Infectious Disease Society (SPILF)
- German Society of Infectious Diseases (DGI)
- Scottish Microbiology Association (SMA)
- Infection Prevention Society (IPS)
- Swedish Society of Infectious Diseases
Major Universities related to Infectious Diseases around the World
- University of Cambridge
- Kings College of London
- London School of Hygiene and Tropical Medicine
- Imperial College London
- UCL Institute of Epidemiology and Healthcare
- Pediatric Infectious Diseases Society
- University of Sheffield
- University of Maryland
- Swedish Institute for Infectious Disease Control
- Columbia University
- University of Gothenburg
- Oslo University
- University of Otago
- University of Pittsburgh
- Emory Health Sciences
- Uppsala University
- University of Liverpool
To share your views and research, please click here to register for the Conference.